Ameritas Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Ameritas Advisory Services's ARKG Position: Q4 2025 in Review
Ameritas Advisory Services sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 813 shares — an estimated $22.6K sold.
Ameritas Advisory Services first reported a position in ARKG in Q4 2021 and held it in 15 quarters. The position peaked at $2.93M in Q4 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.
- Ameritas Advisory Services reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
- Ameritas Advisory Services sold 813 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $22.6K.
- Ameritas Advisory Services first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 15 quarters.
- Ameritas Advisory Services's ARK Genomic Revolution ETF position peaked at $2.93M in Q4 2021.
- 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.
Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.